Regenxbio Price Cash Flow Ratio from 2010 to 2025

RGNX Stock  USD 7.91  0.29  3.54%   
Regenxbio Price Cash Flow Ratio yearly trend continues to be fairly stable with very little volatility. Price Cash Flow Ratio will likely drop to -2.32 in 2025. During the period from 2010 to 2025, Regenxbio Price Cash Flow Ratio regression line of annual values had r-squared of  0.63 and arithmetic mean of (48.10). View All Fundamentals
 
Price Cash Flow Ratio  
First Reported
2010-12-31
Previous Quarter
(2.21)
Current Value
(2.32)
Quarterly Volatility
65.02742641
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17 M, Interest Expense of 16.3 M or Selling General Administrative of 50.8 M, as well as many indicators such as Price To Sales Ratio of 4.36, Dividend Yield of 0.0 or PTB Ratio of 1.55. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Price Cash Flow Ratio Growth Pattern

Below is the plot of the Price Cash Flow Ratio of Regenxbio over the last few years. It is Regenxbio's Price Cash Flow Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Price Cash Flow Ratio10 Years Trend
Slightly volatile
   Price Cash Flow Ratio   
       Timeline  

Regenxbio Price Cash Flow Ratio Regression Statistics

Arithmetic Mean(48.10)
Geometric Mean18.65
Coefficient Of Variation(135.18)
Mean Deviation57.26
Median(10.09)
Standard Deviation65.03
Sample Variance4,229
Range182
R-Value0.79
Mean Square Error1,697
R-Squared0.63
Significance0.0003
Slope10.80
Total Sum of Squares63,428

Regenxbio Price Cash Flow Ratio History

2025 -2.32
2024 -2.21
2023 -3.59
2022 -4.72
2021 6.34
2020 -31.28
2019 -13.96

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Price Cash Flow Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Cash Flow Ratio(2.21)(2.32)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.